ClearOne, Inc. Common Stock (CLRO) is a publicly traded Technology sector company. As of November 8, 2026, CLRO trades at $4.97 with a market cap of $13.40M and a P/E ratio of -0.37. CLRO moved +11.45% today. Year to date, CLRO is -4.83%; over the trailing twelve months it is -3.28%. Its 52-week range spans $1.62 to $16.50. Rallies surfaces CLRO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Vivani says Cortigent-ClearOne deal awaits final regulatory approval: Vivani Medical said its deal to make Cortigent a wholly owned subsidiary of ClearOne remains pending final regulatory approval. The parties now expect to complete the transaction shortly after approval, rather than the previously anticipated October 2026 closing.
| Metric | Value |
|---|---|
| Price | $4.97 |
| Market Cap | $13.40M |
| P/E Ratio | -0.37 |
| EPS | $-10.85 |
| Dividend Yield | 0.50% |
| 52-Week High | $16.50 |
| 52-Week Low | $1.62 |
| Volume | 460.51K |
| Avg Volume | 0 |
| Revenue (TTM) | $-415.00K |
| Net Income | $-20.08M |
| Gross Margin | 100.00% |
CLRO analyst coverage data. Average price target: $0.00.